| Literature DB >> 24196276 |
Jason A Cascio1, Marie-Therese Khairallah1, Xiaoxiao Wan1, Weirong Chen1, Linda M Rowland1, Mermagya Dhakal1, Mindy M Miller1, Habib Zaghouani2.
Abstract
F1 (SJL/J×C57BL/6) mice with MOG35-55-induced EAE recover from disease when treated with Ig-MOG carrying MOG35-55 peptide. However, Ig-PLP1, carrying PLP139-151, induced reduction of anti-MOG antibodies and exacerbated EAE. Herein, we show that Ig-PLP1 specifically reduces the frequency of B cells producing protective IgG2a/b anti-MOG antibodies. Surprisingly, these cells were marginal zone (MZ), rather than follicular (FO) or newly formed (NF), B cells and transfer of MZ B cells into sick mice nullified disease exacerbation by Ig-PLP1 in a complement dependent manner. These findings reveal a potential self-limiting regulatory mechanism involving auto-antibodies in MOG EAE.Entities:
Keywords: Anti-MOG antibodies; Autoimmunity; B cells; EAE; T cell tolerance
Mesh:
Substances:
Year: 2013 PMID: 24196276 PMCID: PMC4762480 DOI: 10.1016/j.jneuroim.2013.09.022
Source DB: PubMed Journal: J Neuroimmunol ISSN: 0165-5728 Impact factor: 3.478